duligotuzumab inn bispecific humanized monoclonal antibody designed treatment cancer acts immunomodulator binds egfr development roche clinical development head neck cancer colorectal cancer discontinued phase trials combination cobimetinib evaluating safety treatment solid monoclonal article stub help wikipedia expanding ithttpsenwikipediaorgwikiduligotuzumab